Ignite Creation Date:
2025-12-25 @ 4:49 AM
Ignite Modification Date:
2026-03-08 @ 11:01 PM
Study NCT ID:
NCT01355718
Status:
COMPLETED
Last Update Posted:
2014-08-11
First Post:
2011-05-13
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Observational, Safety Study of NovoNorm® (Repaglinide) and Insulin Analogue Combination Therapy in Type 2 Diabetes in Korea
Sponsor:
Novo Nordisk A/S
Organization: